ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,246Medicare Part D Prescriptions Filled, Including Refills

Rank: 110 out of 5176

$956K Total Retail Price of All Prescriptions

Rank: 291 out of 5176

724 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 724 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

5% of this provider’s 724 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 17,865 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
LEVOTHYROXINE SODIUM 1,040 995 1 4
SIMVASTATIN 1,035 915 2 1
WARFARIN SODIUM 908 883 3 13
METOPROLOL TARTRATE 876 803 4 6
OMEPRAZOLE 842 790 5 3
FUROSEMIDE 756 714 6 8
LISINOPRIL 633 579 7 5
AMLODIPINE BESYLATE 632 618 8 2
DONEPEZIL HCL 387 382 9 28
GABAPENTIN 324 308 10 21
MIRTAZAPINE 317 315 11 45
METFORMIN HCL 308 257 12 7
CITALOPRAM HBR 258 252 13 31
NAMENDA 250 250 14 47
ALENDRONATE SODIUM 239 230 15 18
ATORVASTATIN CALCIUM 226 204 16 9
RISPERIDONE 192 188 17 78
QUETIAPINE FUMARATE 188 166 18 75
ATENOLOL 172 161 19 12
TRAZODONE HCL 163 161 20 71
PAROXETINE HCL 160 159 21 93
GEMFIBROZIL 156 116 22 139
METOPROLOL SUCCINATE 155 155 23 11
DIGOXIN 152 140 24 56
ISOSORBIDE MONONITRATE ER 151 138 25 44
POTASSIUM CHLORIDE 148 148 26 34
RANITIDINE HCL 140 139 27 36
SERTRALINE HCL 132 132 28 30
HYDROCHLOROTHIAZIDE 129 115 29 10
TAMSULOSIN HCL 127 110 30 20
LOSARTAN POTASSIUM 123 120 31 14
HYDROCODONE-ACETAMINOPHEN 120 109 S3 32 27
GLIPIZIDE 117 117 33 63
ZETIA 116 97 34 68
PREDNISONE 116 108 34 52
ALLOPURINOL 112 105 36 41
FINASTERIDE 111 99 37 69
HYDRALAZINE HCL 107 92 38 73
ADVAIR DISKUS 105 94 39 32
GLYBURIDE 103 78 R 40 67
CARBIDOPA-LEVODOPA 102 102 41 98
CARVEDILOL 98 88 42 24
PANTOPRAZOLE SODIUM 97 95 43 61
JANUVIA 97 77 43 25
SULFAMETHOXAZOLE-TRIMETHOPRIM 97 95 43 181
EXELON 97 97 43 162
FLUOXETINE HCL 95 95 47 132
LANTUS 94 75 48 66
LIDODERM 93 70 49 59
CYMBALTA 89 87 50 90
NEXIUM 85 73 51 16
NYSTATIN 84 76 52 168
LOVASTATIN 84 84 52 46
OLANZAPINE 84 78 52 140
ESCITALOPRAM OXALATE 81 81 55 89
AGGRENOX 80 80 56 235
SEROQUEL 79 74 57 166
HALOPERIDOL 78 59 58 145
EVISTA 78 78 58 65
FLUTICASONE PROPIONATE 75 54 60 38
CLOPIDOGREL 75 67 60 26
LEVETIRACETAM 69 68 62 92
FENTANYL 66 66 S2 63 172
DIVALPROEX SODIUM 64 59 64 104
SPIRIVA 64 64 64 54
IBUPROFEN 62 61 66 72
CIPROFLOXACIN HCL 61 59 67 84
NYSTOP 60 59 68 283
LANSOPRAZOLE 58 58 69 113
BUPROPION HCL SR 58 52 69 320
KLOR-CON M20 58 58 69 129
CEPHALEXIN 58 57 69 189
METOCLOPRAMIDE HCL 56 43 73 176
CLONIDINE HCL 55 53 74 79
CLOZAPINE 55 36 74 269
LABETALOL HCL 54 48 76 114
ALCOHOL PREP PADS 51 35 77 198
TRAMADOL HCL 51 51 77 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 15, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.